Leading healthtech company Cognota Healthcare on Monday announced that the United States Food and Drug Administration (US FDA) has approved the company’s blood pressure monitor device- ‘COGNOHEALTH Blood Pressure Monitor’, marking the successful foray of the company into the medical devices segment.
The regulatory approval is a significant milestone for Cognota which can now export its blood pressure monitor devices to the US, Europe, and other overseas countries along with tapping the burgeoning Indian market.